Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2013 (2013), Article ID 943761, 4 pages
http://dx.doi.org/10.1155/2013/943761
Review Article

Matrix Metalloproteinases in Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage

Department of Neurosurgery, University of Southern California, 1200 North State Street, Suite 3300, Los Angeles, CA 90033, USA

Received 6 November 2012; Accepted 9 March 2013

Academic Editor: Jay Mocco

Copyright © 2013 Vivek Mehta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Feiler, N. Plesnila, S. C. Thal, S. Zausinger, and K. Schöller, “Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage,” Cerebrovascular Diseases, vol. 32, no. 3, pp. 289–295, 2011. View at Publisher · View at Google Scholar
  2. J. P. Broderick, T. G. Brott, J. E. Duldner, T. Tomsick, and A. Leach, “Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage,” Stroke, vol. 25, no. 7, pp. 1342–1347, 1994. View at Google Scholar · View at Scopus
  3. A. S. Dumont, R. J. Dumont, M. M. Chow et al., “Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation,” Neurosurgery, vol. 53, no. 1, pp. 123–135, 2003. View at Google Scholar · View at Scopus
  4. S. C. Kim, M. Singh, J. Huang et al., “Matrix metalloproteinase-9 in cerebral aneurysms,” Neurosurgery, vol. 41, no. 3, pp. 642–647, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. V. W. Yong, C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards, “Matrix metalloproteinases and diseases of the CNS,” Trends in Neurosciences, vol. 21, no. 2, pp. 75–80, 1998. View at Google Scholar · View at Scopus
  6. L. J. McCawley and L. M. Matrisian, “Matrix metalloproteinases: multifunctional contributors to tumor progression,” Molecular Medicine Today, vol. 6, no. 4, pp. 149–156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Horstmann, Y. Su, J. Koziol, U. Meyding-Lamadé, S. Nagel, and S. Wagner, “MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage,” Journal of the Neurological Sciences, vol. 251, no. 1-2, pp. 82–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. S. Galis, R. Kranzhöfer, J. W. Fenton, and P. Libby, “Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 3, pp. 483–489, 1997. View at Google Scholar · View at Scopus
  9. Z. Li, L. Li, H. R. Zielke et al., “Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions,” American Journal of Pathology, vol. 148, no. 1, pp. 121–128, 1996. View at Google Scholar · View at Scopus
  10. Z. S. Galis, G. K. Sukhova, R. Kranzhöfer, S. Clark, and P. Libby, “Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 2, pp. 402–406, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Romanic and J. A. Madri, “The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent,” Journal of Cell Biology, vol. 125, no. 5, pp. 1165–1178, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Menashi, H. Lu, C. Soria, and Y. Legrand, “Endothelial cell proteases: physiological role and regulation,” Bailliere's Clinical Haematology, vol. 6, no. 3, pp. 559–576, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. H. E. van Wart and H. Birkedal-Hansen, “The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 14, pp. 5578–5582, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. P. E. van den Steen, B. Dubois, I. Nelissen, P. M. Rudd, R. A. Dwek, and G. Opdenakker, “Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9),” Critical Reviews in Biochemistry and Molecular Biology, vol. 37, no. 6, pp. 375–536, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hayashita-Kinoh, H. Kinoh, A. Okada et al., “Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth,” Cell Growth and Differentiation, vol. 12, no. 11, pp. 573–580, 2001. View at Google Scholar · View at Scopus
  16. L. Y. S. Oh, P. H. Larsen, C. A. Krekoski et al., “Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligoclendrocytes,” Journal of Neuroscience, vol. 19, no. 19, pp. 8464–8475, 1999. View at Google Scholar · View at Scopus
  17. P. Frölichsthal-Schoeller, A. L. Vescovi, C. A. Krekoski, G. Murphy, D. R. Edwards, and P. Forsyth, “Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells,” NeuroReport, vol. 10, no. 2, pp. 345–351, 1999. View at Google Scholar · View at Scopus
  18. N. W. Seeds, L. B. Siconolfi, and S. P. Haffke, “Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding,” Cell and Tissue Research, vol. 290, no. 2, pp. 367–370, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Visse and H. Nagase, “Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry,” Circulation Research, vol. 92, no. 8, pp. 827–839, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Brew, D. Dinakarpandian, and H. Nagase, “Tissue inhibitors of metalloproteinases: evolution, structure and function,” Biochimica et Biophysica Acta, vol. 1477, no. 1-2, pp. 267–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Chou, S. K. Feske, S. L. Simmons et al., “Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage,” Translational Stroke Research, vol. 2, no. 4, pp. 600–607, 2011. View at Google Scholar
  22. M. L. Cuzner and G. Opdenakker, “Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system,” Journal of Neuroimmunology, vol. 94, no. 1-2, pp. 1–14, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Satoh, I. Date, T. Ohmoto, E. Perkins, and A. D. Parent, “The expression and activation of matrix metalloproteinase-1 after subarachnoid haemorrhage in rats,” Acta Neurochirurgica, vol. 147, no. 2, pp. 187–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. D. Pins, M. E. Collins-Pavao, L. Van De Water, M. L. Yarmush, and J. R. Morgan, “Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices,” Journal of Investigative Dermatology, vol. 114, no. 4, pp. 647–653, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. K. A. Scott, E. J. Wood, and E. H. Karran, “A matrix metalloproteinase inhibitor which prevents fibroblast-mediated collagen lattice contraction,” FEBS Letters, vol. 441, no. 1, pp. 137–140, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Gaetani, R. Rodriguez Y Baena, F. Tartara et al., “Metalloproteases and intracranial vascular lesions,” Neurological Research, vol. 21, no. 4, pp. 385–390, 1999. View at Google Scholar · View at Scopus
  27. G. Bruno, R. Todor, I. Lewis, and D. Chyatte, “Vascular extracellular matrix remodeling in cerebral aneurysms,” Journal of Neurosurgery, vol. 89, no. 3, pp. 431–440, 1998. View at Google Scholar · View at Scopus
  28. D. R. Todor, I. Lewis, G. Bruno, and D. Chyatte, “Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2,” Stroke, vol. 29, no. 8, pp. 1580–1583, 1998. View at Google Scholar · View at Scopus
  29. S. Horstmann, P. Kalb, J. Koziol, H. Gardner, and S. Wagner, “Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies,” Stroke, vol. 34, no. 9, pp. 2165–2170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. McGirt, J. R. Lynch, R. Blessing et al., “Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 51, no. 5, pp. 1128–1135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. F. A. Sehba, G. Mostafa, J. Knopman, V. Friedrich, and J. B. Bederson, “Acute alterations in microvascular basal lamina after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 4, pp. 633–640, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. F. T. Bosman, J. Cleutjens, C. Beek, and M. Havenith, “Basement membrane heterogeneity,” Histochemical Journal, vol. 21, no. 11, pp. 629–633, 1989. View at Google Scholar · View at Scopus
  33. J. R. Stanley, D. T. Woodley, S. I. Katz, and G. R. Martin, “Structure and function of basement membrane,” Journal of Investigative Dermatology, vol. 79, no. 1, pp. 69s–72s, 1982. View at Google Scholar · View at Scopus
  34. P. Vikman, S. Ansar, and L. Edvinsson, “Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats: laboratory investigation,” Journal of Neurosurgery, vol. 107, no. 5, pp. 1015–1022, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Guo, X. Sun, Z. He, Y. Jiang, and X. Zhang, “Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage,” Neurological Sciences, vol. 31, no. 2, pp. 143–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Wang, Q. Fang, B.-Q. Dang et al., “Potential contribution of matrix metalloproteinase-9 (mmp-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats,” Annals of Clinical & Laboratory Science, vol. 42, no. 1, pp. 14–20, 2012. View at Google Scholar
  37. M. Dittmar, G. Kiourkenidis, M. Horn, S. Bollwein, and G. Bernhardt, “Cerebral ischemia, matrix metalloproteinases, and TNF-alpha: MMP inhibitors may act not exclusively by reducing MMP activity,” Stroke, vol. 35, no. 7, pp. e338–e340, 2004. View at Google Scholar · View at Scopus
  38. A. Reijerkerk, G. Kooij, S. M. A. van der Pol, S. Khazen, C. D. Dijkstra, and H. E. de Vries, “Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells,” FASEB Journal, vol. 20, no. 14, pp. E1901–E1909, 2006. View at Publisher · View at Google Scholar · View at Scopus